DE FERRARI, GAETANO
 Distribuzione geografica
Continente #
NA - Nord America 3.810
EU - Europa 2.357
AS - Asia 2.289
AF - Africa 8
OC - Oceania 5
SA - Sud America 5
Continente sconosciuto - Info sul continente non disponibili 3
Totale 8.477
Nazione #
US - Stati Uniti d'America 3.739
CN - Cina 2.087
IE - Irlanda 1.023
FI - Finlandia 310
IT - Italia 288
DE - Germania 248
UA - Ucraina 224
SG - Singapore 142
SE - Svezia 95
GB - Regno Unito 83
CA - Canada 71
FR - Francia 31
IN - India 23
BE - Belgio 21
RU - Federazione Russa 9
AT - Austria 8
JP - Giappone 8
ID - Indonesia 6
HK - Hong Kong 5
NL - Olanda 5
AU - Australia 4
MU - Mauritius 4
MY - Malesia 4
BR - Brasile 3
ES - Italia 3
EU - Europa 3
KE - Kenya 3
TR - Turchia 3
AE - Emirati Arabi Uniti 2
AR - Argentina 2
CZ - Repubblica Ceca 2
DK - Danimarca 2
IL - Israele 2
IR - Iran 2
KW - Kuwait 2
PL - Polonia 2
RO - Romania 2
GR - Grecia 1
IQ - Iraq 1
NG - Nigeria 1
NZ - Nuova Zelanda 1
SA - Arabia Saudita 1
VN - Vietnam 1
Totale 8.477
Città #
Dublin 1.021
Chandler 746
Nanjing 655
Jacksonville 596
Ashburn 279
Nanchang 260
Boardman 243
Princeton 206
Lawrence 198
Medford 187
Shenyang 172
Wilmington 172
Changsha 171
Hebei 155
Jiaxing 145
Beijing 142
Helsinki 139
Hangzhou 104
Tianjin 100
Singapore 85
Pavia 79
Ann Arbor 77
New York 58
Mcallen 52
Shanghai 49
Munich 44
Montréal 37
Norwalk 37
Dearborn 33
Woodbridge 33
Fairfield 32
Milan 32
Seattle 21
Los Angeles 18
Ottawa 18
Brussels 17
Jinan 14
Pune 14
Redwood City 14
Verona 14
Des Moines 11
Zhengzhou 11
Chieti 10
Kunming 10
Ningbo 10
Toronto 10
Guangzhou 9
Tokyo 8
Washington 8
Catanzaro 7
Pescara 7
Changchun 6
Fuzhou 6
Jakarta 6
Rome 6
Vienna 6
Auburn Hills 5
Chicago 4
Leuven 4
Orange 4
Vancouver 4
Berlin 3
Ferrara 3
Melbourne 3
Rio de Janeiro 3
San Francisco 3
Seregno 3
Seri Kembangan 3
Taizhou 3
Turin 3
Walnut 3
Bari 2
Barletta 2
Biassono 2
Bologna 2
Borås 2
Brno 2
Buenos Aires 2
Copenhagen 2
Dallas 2
Eden Prairie 2
Florence 2
Francavilla Al Mare 2
Frankfurt am Main 2
Gmunden 2
Hanover 2
Hefei 2
Kemerovo 2
Kuwait City 2
Lodz 2
Monmouth Junction 2
Montoro 2
Napoli 2
New Delhi 2
Novokuznetsk 2
Nuremberg 2
Palermo 2
Piscataway 2
Sant'Ambrogio di Torino 2
Sant'Angelo Lodigiano 2
Totale 6.709
Nome #
Vagus nerve stimulation: from pre-clinical to clinical application: challenges and future directions. 221
Identificazione di microRNA circolanti specificatamente sovra espressi in corso di infarto miocardico acuto. 217
PREDESTINATION: PRimary vEntricular fibrillation and suDden dEath during a firST myocardIal iNfArcTION: Genetic basis. 96
Gene symbol: KCNH2 85
Antidepressants: their effects on cardiac channels, QT prolongation and Torsade de Pointes 78
Successful repair of lateral wall pseudoaneurysm via left anterior minithoracotomy using port-access tecnique 75
Atrial arrhythmias prevalence in heart transplant patients. 71
Scopolamine increases vagal tone and vagal reflexes in patients after myocardial infarction 71
Ranolazine in the treatment of atrial fibrillation: Results of the dose-ranging RAFFAELLO (ranolazine in atrial fibrillation following an electrical cardioversion) study 71
Autonomic mechanisms and sudden death. New insights from analysis of baroreceptor reflexes in conscious dogs with and without a myocardial infarction. 70
A challenging case of permanent junctional reciprocating tachycardia (pjrt) in post-partum cardiogenic shock 67
Scopolamine increases vagal tone and vagal reflexes in patients after myocardial infarction. 65
Remote ischemic postconditioning as a strategy to reduce acute kidney injury during primary PCI: A post-hoc analysis of a randomized trial 64
Drug eluting stents are superior to bare metal stents to reduce clinical outcome and stent-related complications in CKD patients, a systematic review, meta-analysis and network meta-analysis 64
Significant left ventricular reverse remodelling following radiofrequency ablation of monomorphic ventricular ectopy in pts with idiopathic cardiomyopathy 62
Gene symbol: SCN5A 62
Protective effect of vagal stimulation on reperfusion arrhythmias in cats. 62
Effects of Intra-Aortic Balloon Pump on Markers of Right Ventricular Dysfunction Among End-Stage Heart Failure Patients Candidates to Cardiac Transplant or Ventricular Assist Device 61
Chronic vagus nerve stimulation (CVNS) – A new target for treatment of congestive heart failure. 61
Thromboembolism after atrioventricular node ablation and pacing: long term follow up. 60
Closure of patent foramen ovale or medical therapy alone for secondary prevention of cryptogenic cerebrovascular events 60
Efficacy versus safety: The dilemma of using novel platelet inhibitors for the treatment of patients with ischemic stroke and coronary artery disease 60
Strategies for reducing door to balloon time in patients with acute myocardial infarction undergoing primary angioplasty: the Pavia experience 60
Sympathetic-parasympathetic interaction in health and disease: abnormalities and relevance in heart failure. 59
Past and future of the "Pavia eCPR program" 59
Baroreflex sensitivity predicts long-term cardiovascular mortality after myocardial infarction even in patients with preserved left ventricular function. 58
[Vagus nerve stimulation for the treatment of heart failure] 58
KCNH2-K897T Is a Genetic Modifier of Latent Congenital Long-QT Syndrome. 57
Hospital survival and long term quality of life after emergency institution of venoarterial ECMO for refractory circulatory collapse. 57
Atherothrombotic Risk Stratification and the Efficacy and Safety of Vorapaxar in Patients with Stable Ischemic Heart Disease and Previous Myocardial Infarction 57
[Baroceptive reflex sensibility in non-anesthetized animals. Evaluation and comparison of 2 methods applicable to humans]. 57
Use of extracorporeal membrane oxygenation in primary refractory cardiac shock and cardiac arrest; a single centre experience 56
Response to Letters Regarding Article, "Clinical Management of Catecholaminergic Polymorphic Ventricular Tachycardia: The Role of Left Cardiac Sympathetic Denervation" 56
Prevalence and features of incessant atrial arrhythmias after heart transplantation with standard technique. 55
Gene symbol: KCNH2 55
The prognostic value of late gadolinium enhancement in hypertrophic cardiomyopathy: An updated meta-analysis 55
Two-to-one AV block associated with the congenital long QT syndrome. 54
Prevalenza della aritmie atriali nei pazienti sottoposti a trapianto cardiaco ortotopico secondo la tecnica di Lower e Shumway 54
Autonomic Modulation for the Management of Patients with Chronic Heart Failure 54
Gene symbol: KCNQ1 54
Baroreceptor reflexes and sudden cardiac death: experimental findings and background. 54
High-dose erythropoietin in patients with acute myocardial infarction: a pilot, randomised, placebo-controlled study. 53
Protective effect of vagal hyperactivity on reperfusion arrhythmias 53
Autonomic nervous system and arrhythmias. 53
Chemokines and Heart Disease: A Network Connecting Cardiovascular Biology to Immune and Autonomic Nervous Systems 53
Acute Kidney Injury Definition and In-Hospital Mortality in Patients Undergoing Primary Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction 53
Comparison of Outcomes of Staged Complete Revascularization Versus Culprit Lesion–Only Revascularization for ST-Elevation Myocardial Infarction and Multivessel Coronary Artery Disease 53
Left cardiac sympathetic denervation in patients with heart failure: A new indication for an old intervention? 53
Do increases in markers of vagal activity imply protection from sudden death? The case of scopolamine. 52
Pharmacologic modulation of the autonomic nervous system in the prevention of sudden cardiac death. A study with propranolol, methacholine and oxotremorine in conscious dogs with a healed myocardial infarction. 52
Impaired baroreflex sensitivity is correlated with hemodynamic deterioration of sustained ventricular tachycardia. 52
Extracorporeal membrane oxigenation support decreases mortality in acute myocardial infarction complicated by refractory cardiogenic shock 52
[Sudden death after myocardial infarction. Prediction based on the baroreceptor reflex]. 52
Atrial fibrillation requiring urgent medical care. Approach and outcome in the various departments of admission. Data from the atrial Fibrillation/flutter Italian REgistry (FIRE). 52
Left cardiac sympathetic denervation for the prevention of life-threatening arrhythmias: the surgical supraclavicular approach to cervicothoracic sympathectomy. 51
Rapid recovery of baroreceptor reflexes in acute myocardial infarction is a marker of effective tissue reperfusion 51
Clinical neurocardiology defining the value of neuroscience-based cardiovascular therapeutics. 51
Prognostic Impact of in-Hospital-Bleeding in Patients With ST-Elevation Myocardial Infarction Treated by Primary Percutaneous Coronary Intervention 51
End-tidal carbon dioxide and defibrillation success in out-of-hospital cardiac arrest 51
Smoker's paradox in ST-elevation myocardial infarction: Role of inflammation and platelets 51
Left cardiac sympathetic denervation for the prevention of life-threatening arrhythmias: the surgical supraclavicular approach to cervicothoracic sympathectomy 50
Clinical management of catecholaminergic polymorphic ventricular tachycardia the role of left cardiac sympathetic denervation 50
Prevention of life-threatening arrhythmias by pharmacologic stimulation of the muscarinic receptors with oxotremorine. 49
Vagal stimulation for heart failure: background and first in-man study. 49
Torsades de Pointes following Acute Myocardial Infarction: Evidence for a Deadly Link with a Common Genetic Variant. 49
Patient Outcomes With STEMI Caused by Aneurysmal Coronary Artery Disease and Treated With Primary PCI 49
Elevated serum uric acid affects myocardial reperfusion and infarct size in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention 49
IntErnationaL eLeCTRicAl storm registry (ELECTRA): Background, rationale, study design, and expected results 49
Vagal stimulation and prevention of sudden death in conscious dogs with a healed myocardial infarction. 48
Amiodarone 48
Sympathetic-parasympathetic interaction and accentuated antagonism in conscious dogs 47
Autonomic reflexes and ventricular tachycardia. 47
Arterial baroreflexes and ventricular tachycardia. 47
Elucidating arrhythmogenic mechanisms of long-QT syndrome CALM1-F142L mutation in patient-specific induced pluripotent stem cell-derived cardiomyocytes 47
Clinical Benefit of Evolocumab by Severity and Extent of Coronary Artery Disease: An Analysis from FOURIER. 47
Angiography- versus physiology-guided complete revascularization in patients with STEMI and multivessel disease: who's the better gatekeeper in this setting? 47
Long term vagal stimulation in patients with advanced heart failure: first experience in man. 46
Favourable effects of heart rate reduction with intravenous administration of ivabradine in patients with advanced heart failure. 46
Letter by Ferrari et al regarding article, "long-term arrhythmia-free survival in patients with severe left ventricular dysfunction and no inducible ventricular tachycardia after myocardial infarction" 46
Le cicatrici degli interventi chirurgici di compartimentalizzazione atriale possono condurre a distanza dalla procedura? 46
Favorable effect of glycoprotein IIbIIIa inhibitors among STEMI patients treated with primary PCI and incomplete ST resolution 45
Clinical governance programme in patients with acute coronary syndrome: Design and methodology of a quality improvement initiative 45
The Common Long QT Syndrome mutation KCNQ1/A341V causes unusually severe clinical manifestations in patients with different ethnic backgrounds: toward a mutation-specific risk stratification. 44
Baroreflex sensitivity, but not heart rate variability, is reduced in patients with life-threatening ventricular arrhythmias long after myocardial infarction. 44
Pathophysiological rationale for cardiac vagal denervation in the treatment of atrial fibrillation 44
Atrial fibrillation in heart failure patients: prevalence in daily practice and effect on the severity of symptoms. Data from the ALPHA study registry. 44
Vox clamantis in deserto. We spoke but nobody was listening: echocardiography can help risk stratification of the long-QT syndrome. 44
Contemporary data on treatment practices for low-density lipoprotein cholesterol in 3867 patients who had suffered an acute coronary syndrome across the world 44
Gene symbol: SCN5A. 44
Risk factors for primary ventricular fibrillation during a first myocardial infarction: Clinical findings from PREDESTINATION (PRimary vEntricular fibrillation and suDden dEath during firST myocardIal iNfArcTION) 44
QT interval and baroreflex sensitivity in conscious dogs before and after myocardial infarction 43
Carbon monoxide and lethal arrhythmias in conscious dogs with a healed myocardial infarction. 43
Cardiovascular Safety and Efficacy of the PCSK9 Inhibitor Evolocumab in Diabetes and the Risk of Development of Diabetes: A Prespecified Analysis from the Randomized Controlled FOURIER Trial 43
Amiodarone in the treatment of Atrial Fibrillation: New Perspectives from Clinical Trials 42
Effects of vagal stimulation in conscious dogs with previous myocardial infarct. 42
Universal Classification System Type of Incident Myocardial Infarction in Patients With Stable Atherosclerosis: Observations From Thrombin Receptor Antagonist in Secondary Prevention of Atherothrombotic Ischemic Events (TRA 2°P)-TIMI 50 42
Vorapaxar for secondary prevention of thrombotic events for patients with previous myocardial infarction: a prespecified subgroup analysis of the TRA 2°P-TIMI 50 trial 42
Post-partum cardiogenic shock in a patient with permanent junctional re-entry tachycardia. 42
Vagal stimulation in heart failure 41
Calmodulin mutations associated with recurrent cardiac arrest in infants. 41
Totale 5.680
Categoria #
all - tutte 39.348
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 39.348


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020580 0 0 0 0 10 54 20 97 6 190 153 50
2020/2021627 57 38 12 44 21 56 3 191 14 128 53 10
2021/2022791 10 1 14 14 5 27 9 51 46 16 121 477
2022/20232.402 306 164 22 153 197 216 2 105 1.154 15 48 20
2023/2024898 54 258 24 56 62 248 34 59 6 32 41 24
2024/2025410 56 236 57 54 7 0 0 0 0 0 0 0
Totale 8.790